Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6731
-0.0114 (-1.67%)
Aug 18, 2026, 12:47 PM EDT - Market open
Standard BioTools Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 84.6 | 85.33 | 91.01 | 106.34 | 97.95 | 130.58 |
Revenue Growth | -4.78% | -6.24% | -14.42% | 8.57% | -24.99% | -5.47% |
Gross Profit Gross Profit Growth | 42.71 | 42.54 | 44.88 | 50.45 | 37.05 | 31.43 |
Operating Income Operating Income Growth | -62.64 | -93.31 | -87.01 | -63.04 | -99.09 | -67.46 |
Net Income Net Income Growth | 84.91 | -74.9 | -184.9 | -74.66 | -190.1 | -59.24 |
Earnings Per Share EPS Growth | 0.22 | -0.20 | -0.52 | -0.94 | -2.43 | -0.78 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Americas Excl. United States Americas Excl. United States Growth | 2.16 | 2 | 2.1 | 2.98 | 3.68 |
Emea Excl. Sweden Emea Excl. Sweden Growth | 27.39 | 26.55 | 29.82 | - | - |
Sweden Sweden Growth | 8.6 | 9.1 | 6.38 | - | - |
United States United States Growth | 28.4 | 35.4 | 44.1 | 41 | 60.2 |
Asia-Pacific (Excl. China) Asia-Pacific (Excl. China) Growth | 7.88 | 7.95 | 7.99 | 10.06 | 11.48 |
China China Growth | 10.9 | 10.01 | 15.95 | 10.77 | 12.5 |
Total Total Growth | 85.33 | 91.01 | 106.34 | 97.95 | 130.58 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 476.72 | 187.58 | 292.87 | 114.9 | 165.78 | 28.45 |
Total Debt Total Debt Growth | 28.09 | 30.83 | 30.7 | 98.21 | 102.66 | 111.65 |
Net Cash (Debt) Net Cash Growth | 448.63 | 156.75 | 262.18 | 16.69 | 63.13 | -83.2 |
Net Cash Growth | 115.20% | -40.21% | 1471.35% | -73.57% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.16 | 0.41 | 0.74 | 0.21 | 0.81 | -1.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -80.3 | -74.34 | -143.45 | -43.29 | -89.37 | -44.06 |
Capital Expenditures CapEx Growth | -2.28 | -8.3 | -8.36 | -2.83 | -3.83 | -13.26 |
Free Cash Flow Free Cash Flow Growth | -82.58 | -82.65 | -151.81 | -46.12 | -93.2 | -57.33 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.48% | 49.86% | 49.32% | 47.44% | 37.83% | 24.07% |
Operating Margin | -74.04% | -109.34% | -95.60% | -59.28% | -101.17% | -51.66% |
Pretax Margin | -107.55% | -113.33% | -99.33% | -69.78% | -196.97% | -48.75% |
Profit Margin | 100.36% | -87.77% | -203.17% | -70.20% | -194.08% | -45.36% |
FCF Margin | -97.61% | -96.85% | -166.81% | -43.37% | -95.15% | -43.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 3.16 | 5.77 | 7.16 | 1.65 | 0.95 | 2.30 |